0.0008
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
12.5000
Operating Expense
2,014.3020
2,014.3020
2,877.9430
2,892.2950
Operating Income
-2,014.3020
-2,014.3020
-2,877.9430
-2,879.7950
Other Income Expense
79.3350
79.3350
83.9990
180.5590
Pretax Income
-1,934.9670
-1,934.9670
-2,793.9440
-2,699.2360
Tax Provision
--
--
--
-987.3530
Net Income Common Stockholders
-2,248.2600
-2,248.2600
-3,079.5120
-1,997.4500
Diluted NI Available to Com Stockholders
-2,248.2600
-2,248.2600
-3,079.5120
-1,997.4500
Basic EPS
-0.35
--
-0.52
-0.34
Diluted EPS
-0.35
--
-0.52
-0.34
Basic Average Shares
6,458.7390
--
5,881.8980
5,881.8980
Diluted Average Shares
6,458.7390
--
5,881.8980
5,881.8980
Total Operating Income as Reported
-2,014.3020
-2,014.3020
-2,877.9430
-2,879.7950
Total Expenses
2,014.3020
2,014.3020
2,877.9430
2,892.2950
Net Income from Continuing & Discontinued Operation
-1,934.9670
-1,934.9670
-2,793.9440
-1,711.8830
Normalized Income
-1,936.3020
-1,936.3020
-2,877.9430
-1,826.3954
EBIT
-2,014.3020
-2,014.3020
-2,877.9430
-2,879.7950
EBITDA
-992.8090
-992.8090
-1,839.1270
-2,470.4270
Reconciled Depreciation
1,021.4930
1,021.4930
1,038.8160
409.3680
Net Income from Continuing Operation Net Minority Interest
-1,934.9670
-1,934.9670
-2,793.9440
-1,711.8830
Total Unusual Items Excluding Goodwill
1.3350
1.3350
83.9990
180.5590
Total Unusual Items
1.3350
1.3350
83.9990
180.5590
Normalized EBITDA
-994.1440
-994.1440
-1,923.1260
-2,650.9860
Tax Rate for Calcs
--
--
--
0.0004
Tax Effect of Unusual Items
--
--
--
66.0466
12/31/2020 - 4/8/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIANY LianBio
0.2630
0.00%
SQZB SQZ Biotechnologies Company
0.0300
0.00%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
CAMX.ST Camurus AB (publ)
601.00
+1.09%
GNS.L Genus plc
1,478.00
-0.40%
NAVB Navidea Biopharmaceuticals, Inc.
0.0001
0.00%
OXB.L Oxford Biomedica plc
410.00
-0.49%
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
63.50
+1.44%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
PHARM.AS Pharming Group N.V.
0.9105
-2.10%